Clinical Trials

Clinical Trials

A strategic alliance with Scottsdale Healthcare (SHC) provides a direct clinical research site for TGen through the Virginia G. Piper Cancer Center (VGPCC) Clinical Trials.

Led by Dr. Daniel Von Hoff, TGen's Physician-in-Chief, the clinical site offers patients the latest in clinical trial options for ACC.

About the VGPCC Clinical Trials at SHC

VTGen/VGPCC Clinical Trials clinicians focus on clinical trials with targeted agents and genomics-based individualized therapy. The TGen/VGPCC Clinical Trials, with an initial focus on cancer, allows the unique opportunity for TGen to transition its laboratory-based research to patient care centered on individualized therapy.

For example, a study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma (GALACCTIC)is an orally available drug that blocks the chemical pathway that otherwise allows the ACC tumors to grow out of control. OSI-906 is expected to have minimal impact on the healthy tissue of the adrenal glands or their normal function. This study is ongoing, but not recruiting participants.


For all patients inquiring about a particular study, please contact patient care coordinator, Joyce Schaffer.

VGPCC Clinical Trials at SHC
Joyce Schaffer RN MSN AOCNS
Patient Care Coordinator
Scottsdale Healthcare
Virginia G. Piper Cancer Center
10510 N. 92nd Street, Suite 200
Scottsdale, AZ 85258
Office: 480-323-1339
or 1-877-273-3713
Fax: 480-882-5820
[email protected]

To inquire about the ACC Patient Clinic at Scottsdale Healthcare, please contact Maria Rebelo.

Maria Rebelo
Medical Assistant to Dr. Michael Demeure
Scottsdale Healthcare Cancer Surgery
Michael J. Demeure, MD, MBA
Director, Endocrine Tumors Center
10460 N. 92nd Street Suite 200
Scottsdale, AZ 85258
Phone: 480-323-1570
Fax: 480-323-1281
[email protected]

Other Clinical Trial Sites

Find trials for a specific medical condition or other criteria in the registry. is a registry and results database of federally and privately supported clinical trials conducted in the United States and around the world. gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.

Our Mission

The mission of Kirsten’s Legacy is to provide valuable resources to patients and their families while working to cure ACC through identification of new therapies and advancing those discoveries, as quickly as possible, to clinical trials.

How to Get Involved

While ACC is one of most rare and lethal of endocrine cancers, it remains one of the least well funded. Please support our efforts to find new therapies as well as new means of preventing and curing this devastating form of cancer.